BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28109554)

  • 41. Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey.
    Trecarichi EM; Pagano L; Candoni A; Pastore D; Cattaneo C; Fanci R; Nosari A; Caira M; Spadea A; Busca A; Vianelli N; Tumbarello M;
    Clin Microbiol Infect; 2015 Apr; 21(4):337-43. PubMed ID: 25595706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bloodstream infections in pediatric patients.
    Babay HA; Twum-Danso K; Kambal AM; Al-Otaibi FE
    Saudi Med J; 2005 Oct; 26(10):1555-61. PubMed ID: 16228055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bloodstream Infections in Patients with Hematologic Diseases: Causative Organisms and Factors Associated with Resistance.
    Choi H; Ahn H; Lee R; Cho SY; Lee DG
    Infect Chemother; 2022 Jun; 54(2):340-352. PubMed ID: 35794719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors influencing mortality in neutropenic patients with haematologic malignancies or solid tumours with bloodstream infection.
    Marín M; Gudiol C; Ardanuy C; Garcia-Vidal C; Jimenez L; Domingo-Domenech E; Pérez FJ; Carratalà J
    Clin Microbiol Infect; 2015 Jun; 21(6):583-90. PubMed ID: 25680311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Surveillance of bacterial distribution and drug resistance in inpatients with surgical infections: a single center study].
    Jiang KW; Lü Y; Guo P; Ye YJ; Wang H; Wang Q; Zhao CJ; Gao ZD; Cao J; Lü L; Yan YC; Wang S
    Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):604-9. PubMed ID: 24256585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States.
    Wisplinghoff H; Seifert H; Wenzel RP; Edmond MB
    Clin Infect Dis; 2003 May; 36(9):1103-10. PubMed ID: 12715303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial activity of a UV-stable bacteriocin-like inhibitory substance (BLIS) produced by Enterococcus faecium strain DSH20 against vancomycin-resistant Enterococcus (VRE) strains.
    Shokri D; Zaghian S; Khodabakhsh F; Fazeli H; Mobasherizadeh S; Ataei B
    J Microbiol Immunol Infect; 2014 Oct; 47(5):371-6. PubMed ID: 23838264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bloodstream infections and antimicrobial resistance patterns in a South African neonatal intensive care unit.
    Morkel G; Bekker A; Marais BJ; Kirsten G; van Wyk J; Dramowski A
    Paediatr Int Child Health; 2014 May; 34(2):108-14. PubMed ID: 24621234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bloodstream infections in older population: epidemiology, outcome, and impact of multidrug resistance.
    de Laroche M; Fellous L; Salomon E; Saadeh D; Duran C; Bouchand F; Lequintrec JL; Teillet L; Gaillard JL; Seridi Z; Michelon H; Dinh A
    Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1665-1672. PubMed ID: 33694038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases.
    Tofas P; Skiada A; Angelopoulou M; Sipsas N; Pavlopoulou I; Tsaousi S; Pagoni M; Kotsopoulou M; Perlorentzou S; Antoniadou A; Pirounaki M; Skoutelis A; Daikos GL
    Int J Antimicrob Agents; 2016 Apr; 47(4):335-9. PubMed ID: 27005460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period.
    Macesic N; Morrissey CO; Cheng AC; Spencer A; Peleg AY
    Transpl Infect Dis; 2014 Dec; 16(6):887-96. PubMed ID: 25298044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey.
    Trecarichi EM; Giuliano G; Cattaneo C; Ballanti S; Criscuolo M; Candoni A; Marchesi F; Laurino M; Dargenio M; Fanci R; Cefalo M; Delia M; Spolzino A; Maracci L; Nadali G; Busca A; Del Principe MI; Daffini R; Simonetti E; Dragonetti G; Zannier ME; Pagano L; Tumbarello M;
    PLoS One; 2019; 14(10):e0224465. PubMed ID: 31661507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).
    Biedenbach DJ; Moet GJ; Jones RN
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):59-69. PubMed ID: 15380279
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Changing Epidemiology of Bloodstream Infections and Resistance in Hematopoietic Stem Cell Transplantation Recipients.
    Yemişen M; Balkan İİ; Salihoğlu A; Eşkazan AE; Mete B; Ar MC; Öngören Ş; Başlar Z; Özaras R; Saltoğlu N; Mert A; Ferhanoğlu B; Öztürk R; Tabak F; Soysal T
    Turk J Haematol; 2016 Sep; 33(3):216-22. PubMed ID: 25912636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mortality analysis of Enterococcus faecium bloodstream infection in central Taiwan].
    Chang-Hua C; Li-Chen L; Yu-Jun C; Chih-Yen C
    Rev Chilena Infectol; 2016 Aug; 33(4):395-402. PubMed ID: 27905623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection.
    Viasus D; Puerta-Alcalde P; Cardozo C; Suárez-Lledó M; Rodríguez-Núñez O; Morata L; Fehér C; Marco F; Chumbita M; Moreno-García E; Fernández-Avilés F; Gutiérrez-Garcia G; Martínez JA; Mensa J; Rovira M; Esteve J; Soriano A; Garcia-Vidal C
    Clin Microbiol Infect; 2020 Mar; 26(3):345-350. PubMed ID: 31295551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Single Center Analysis of Bloodstream Infection Clinical Characteristics and Prognosis in Patients with Hematological Malignancies in the Tropics].
    Cheng LC; Yang T; Kuang HH; Yu S; Guan LX; Gu ZY; Xu YY; Zheng WS; Wang L; Hu YL; Gao XN; Wang QS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):265-271. PubMed ID: 33554832
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms.
    Rangaraj G; Granwehr BP; Jiang Y; Hachem R; Raad I
    Cancer; 2010 Feb; 116(4):967-73. PubMed ID: 20052728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in hematologic patients in a single cancer center.
    Velasco E; Byington R; Martins CA; Schirmer M; Dias LM; Gonçalves VM
    Eur J Clin Microbiol Infect Dis; 2003 Mar; 22(3):137-43. PubMed ID: 12649710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Laboratory confirmed bloodstream infection aetiology in an intensive care unit: eight years study.
    Orsi GB; Franchi C; Marrone R; Giordano A; Rocco M; Venditti M
    Ann Ig; 2012; 24(4):269-78. PubMed ID: 22913170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.